Results 101 to 110 of about 48,955 (162)

[Two models of insulin resistance development and the strategy to combat age-related diseases: literature review]. [PDF]

Probl Endokrinol (Mosk), 2022
Martyushev-Poklad AV, Yankevich DS, Petrova MV, Savitskaya NG.   +3 more
europepmc   +1 more source

[Cephalgic syndrome in patients with acromegaly]. [PDF]

Probl Endokrinol (Mosk)
Nurullina GN, Pushkarev IN, Przhiyalkovskaya EG.   +2 more
europepmc   +1 more source

[The problem of iodine deficiency in the Chechen republic: assessment of the current state and ways of solution]. [PDF]

Probl Endokrinol (Mosk), 2023
Troshina EA, Makolina NP, Platonova NM, Isaeva MP, Abdulkhabirova FM, Nikankina LV, Zuraeva ZT, Isaeva US, Atabaeva KV.   +8 more
europepmc   +1 more source

[Survival predictors in patients with ectopic acth syndrome]. [PDF]

Probl Endokrinol (Mosk), 2022
Golounina OO, Belaya ZE, Rozhinskaya LY, Pikunov MY, Markovich AA, Dzeranova LK, Marova EI, Kuznetsov NS, Fadeev VV, Melnichenko GA, Dedov II.   +10 more
europepmc   +1 more source

[Diabetes mellitus and cancer: a system of insulin-like growth factors]. [PDF]

Probl Endokrinol (Mosk), 2021
Frantsiyants EM, Surikova EI, Kaplieva IV, Bandovkina VA, Neskubina IV, Sheiko EA, Morozova MI, Kotieva IM.   +7 more
europepmc   +1 more source

[Hepatogenic diabetes: three cases report and literature review]. [PDF]

Probl Endokrinol (Mosk)
Amosova MV, Poluboyarinova IV, Salnikova PV, Zherebchikova KY, Fadeev VV.   +4 more
europepmc   +1 more source

[Characteristics of geriatric and somatic status in patients with osteoporosis]. [PDF]

Probl Endokrinol (Mosk), 2021
Khovasova NO, Naumov AV, Tkacheva ON, Dudinskaya EN.   +3 more
europepmc   +1 more source

[Association between preoperative cholecalciferol therapy and hypocalcemia after parathyroidectomy in patients with primary hyperparathyroidism]. [PDF]

Probl Endokrinol (Mosk)
Elfimova AR, Eremkina AK, Rebrova OY, Kovaleva EV, Mokrysheva NG.   +4 more
europepmc   +1 more source

[Semaglutide - effectiveness in weight loss and side effects when used according to studies by SUSTAIN, PIONEER, STEP]. [PDF]

Probl Endokrinol (Mosk), 2023
Shabutdinova OR, Dautov AR, Samkov AA, Kononenko AV, Sargaliev AF, Davletshin AR, Andresova PA, Zarbeeva KR, Torshkhoeva DA, Rakhmonkulov UA, Afanasyev AA.   +10 more
europepmc   +1 more source

[Development of prognostic clinical and genetic models of the risk of low bone mineral density using neural network training]. [PDF]

Probl Endokrinol (Mosk)
Yalaev BI, Novikov AV, Minniakhmetov IR, Khusainova RI.   +3 more
europepmc   +1 more source